寻买家失败,biotech放弃细胞治疗业务断臂求生

细胞基因治疗前沿
Oct 22, 2025

▲11月6-7日第十届广州(大湾区)生物医药创新者峰会扫码报名声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。继武田制药和诺和诺德先后宣布退出细胞治疗领域后,又一家biotech宣布关闭细胞业务,细胞治疗赛道正经历新一轮残酷洗牌,行业进入理性收缩与调整阶段。10月21日,Galapgos宣布在对战略...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10